Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress

Join Pharma | Login

	Editorial


	THE AYUSHSURAKSHA PORTAL
	Wednesday, June 18, 2025
	Misleading advertisements and health claims by the Ayurveda, Siddha and Unani drug companies have been a major issue the country has been facing for a long time now.
	Past Editorial...

TODAY'S NEWS


13:00 [IST]	Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress
12:50 [IST]	Rubicon Research completes acquisition of Alkem’s Pithampur manufacturing unit for Rs. 149 crore
12:35 [IST]	Biocon Biologics collaborates with National Cancer Society Malaysia to expand affordable access to biosimilars
12:00 [IST]	Illumina to acquire SomaLogic, a leader in data-driven proteomics technology, for $350 million
11:00 [IST]	Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension
10:00 [IST]	Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer

more news >>

TOP NEWS


08:00 [IST]	PCI directs institutions to appoint nodal officer & student ambassador to improve coordination
08:00 [IST]	Africa-Asia Cold Chain Summit 2026 to deliberate resilient, inclusive & sustainable cold chain systems
08:00 [IST]	PLI scheme triggers growth of interdependent value chain in high-precision Medtech: Falgun Jani
08:00 [IST]	India schedules oral hearing in anti-dumping probe on Chinese imports of MIPA
08:00 [IST]	AKCDA elections to be held on June 29, Philip Cheriyan emerges as key challenger to incumbent president AN Mohan
08:00 [IST]	FDI inflow into hospitals & diagnostic centres grew 4 per cent in FY25

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Micropep and Corteva announce research collaboration to co-develop next-generation peptide-based biocontrol solutions
17:45 [IST]	Novo Nordisk GBS walks the talk on inclusion with Pride March and expanded DEIB agenda
17:20 [IST]	Utopia Therapeutics secures $1.5 mn investment from Whale Tank to advance preclinical development of obesity vaccine
16:15 [IST]	Zeno Health scales up physical retail with 75 new stores in Maharashtra with Rs. 30 crore investment
14:15 [IST]	Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple phase 3 trials
12:30 [IST]	Amazon India offers at-home health diagnostics service with sample collection in under 60 minutes & lab results 6 hours across 6 cities

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

NPPA notificaiton dated 3rd June, 2025 fixing retail prices of 41 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 133rd Authority meeting dated 29.5.2025 NPPA notification dated 3rd June, 2025 issuing Corrigendum to S.O 4062 (E) dated 8.11.2019, w.r.t M/s Torrent Pharmaceuticals Ltd NPPA notification dated 6th May, 2025 revising the retail price of 2 applications under Suo Moto framework based on decision of the 132nd Authority meeting dated 29.04.2025 NPPA notification dated 6th May, 2025 revising the ceiling price of one scheduled formulation based on a review order following the decision of the 132nd Authority meeting dated 29.04.2025 NPPA notification dated 6th May, 2025 fixing separate retail price for 3 formulations (new drugs) for M/s Otsuka Pharmaceuticals India Pvt. Ltd. based on decision of the 132nd Authority meeting dated 29.04.2025

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers